Experimental Drug Shows ' Modest ' Benefit in Slowing Advanced Breast Cancer

SATURDAY, June 2, 2018 -- A new and highly targeted drug slowed the growth of advanced breast cancers by about an average of two months, researchers report. " The findings in this study show a modest benefit to a subgroup of women with estrogen...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news